A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection
Article
[키워드] Amino acid
animal
Bivalent
bivalent vaccine
C-terminal
Cellular immune response
conserved
contagious
COVID-19
Delta
delta variant
develop
domain
Ebola
ectodomain
Efficacy
Evidence
fused
global public health
glycoprotein
H1N1
H3N2
hamster
humoral
immunization
infections
Infectious disease
Influenza
influenza A virus
Influenza virus
influenza viruses
M2 protein
mice
Neutralizing
neutralizing antibody
Point mutation
PROTECT
Protein
provide
recombinant
reduced
Respiratory disease
respiratory droplet
respiratory viral
S2 domain
SARS-CoV-2
SARS-CoV-2 Delta variant
SARS-CoV-2 SP
SARS-CoV-2 variant
shown
significantly
Spike protein
the RBD
threat
transmitted
Vaccine
vaccine candidate
vaccine platform
variant
vesicular stomatitis virus
VSV
VSV vector
[DOI] 10.1128/jvi.01337-22 PMC 바로가기
[DOI] 10.1128/jvi.01337-22 PMC 바로가기